July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
M. Bilal Abid: Cell and Gene Therapies are Transforming Patient Care
Jun 18, 2025, 07:08

M. Bilal Abid: Cell and Gene Therapies are Transforming Patient Care

M. Bilal Abid, Clinical Fellow, Hematology/Oncology at The University of Texas Health Science Center at Houston, shared a post on LinkedIn about a paper by Frederick L. Locke et al. published in Blood:

“Cell and gene therapies are transforming patient care. While all other factors related to cell therapy – cell sources, engineering, genetic modifications, need for enhancements, and lymphodepletion – impact efficacy and safety, the manufacturing platform impacts access.
This, at least in part, contributes to access disparities and outcomes as we showed in one of our studies with axi-cel (CD19+ CAR-T). Blacks had a shorter survival (PFS) than other races, possibly related to barriers to access (Graphic below with link).
Happy to end another day in the lab with point of care manufacturing and doing our part to curb disparities!”

Title: Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity

Authors: Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, Armin Ghobadi, Sairah Ahmed, David B. Miklos, Miguel-Angel Perales, Javier Munoz, Warren B. Fingrut, Martina Pennisi, Jordan Gauthier, Mazyar Shadman, Lohith Gowda, Abu-Sayeef Mirza, Muhammad Bilal Abid, Sanghee Hong, Navneet S. Majhail, Mohamed A. Kharfan-Dabaja, Arushi Khurana, Talha Badar, Yi Lin, N. Nora Bennani, Megan M. Herr, Zhen-Huan Hu, Hai-Lin Wang, Anjani Baer, Elande Baro, Harry Miao, Clare Spooner, Hairong Xu, Marcelo C. Pasquini

M. Bilal Abid: Cell and Gene Therapies are Transforming Patient Care

You can read the Full Article in Blood.

More posts featuring M. Bilal Abid.